Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.290
+0.040 (3.20%)
Aug 21, 2026, 4:08 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.62 billion as of August 21, 2026. Its market cap has decreased by -13.83% in one year.
Market Cap
2.62B
Enterprise Value
3.32B
Revenue
2.00B
Ranking
n/a
PE Ratio
50.24
Stock Price
1.29
ChartMarket Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.62B, a decrease of -61.11%. That is a compound annual growth rate of -12.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.62B | 29.00% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viva Biotech Holdings | 3.28B |
| BioDlink International Company | 3.11B |
| Jiangsu Recbio Technology | 3.08B |
| HJ Science | 3.02B |
| Clover Biopharmaceuticals | 2.85B |
| Laekna | 2.73B |
| Antengene Corporation | 2.73B |
| TYK Medicines | 2.68B |